Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2178969
Max Phase: Preclinical
Molecular Formula: C26H30N6O2
Molecular Weight: 458.57
Molecule Type: Small molecule
Associated Items:
ID: ALA2178969
Max Phase: Preclinical
Molecular Formula: C26H30N6O2
Molecular Weight: 458.57
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C([C@@H]1C[C@H](n2cc(-c3ccccn3)nn2)CN1C(=O)CCCc1ccccc1)N1CCCC1
Standard InChI: InChI=1S/C26H30N6O2/c33-25(13-8-11-20-9-2-1-3-10-20)31-18-21(17-24(31)26(34)30-15-6-7-16-30)32-19-23(28-29-32)22-12-4-5-14-27-22/h1-5,9-10,12,14,19,21,24H,6-8,11,13,15-18H2/t21-,24-/m0/s1
Standard InChI Key: OMBBTNGSWHFDOL-URXFXBBRSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 458.57 | Molecular Weight (Monoisotopic): 458.2430 | AlogP: 3.13 | #Rotatable Bonds: 7 |
Polar Surface Area: 84.22 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 0.73 | CX LogP: 2.87 | CX LogD: 2.87 |
Aromatic Rings: 3 | Heavy Atoms: 34 | QED Weighted: 0.54 | Np Likeness Score: -1.30 |
1. Van der Veken P, Fülöp V, Rea D, Gerard M, Van Elzen R, Joossens J, Cheng JD, Baekelandt V, De Meester I, Lambeir AM, Augustyns K.. (2012) P2-substituted N-acylprolylpyrrolidine inhibitors of prolyl oligopeptidase: biochemical evaluation, binding mode determination, and assessment in a cellular model of synucleinopathy., 55 (22): [PMID:23121075] [10.1021/jm301060g] |
Source(1):